NCT05082753

Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions

Randomized, Two-way, Two-period, Single Oral Dose, Open-label, Crossover, Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Humanis Saglık Anonim Sirketi · Industry
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare two tablets of Ivermectin tablets (3 mg Ivermectin) versus two tablets of Stromectol ® tablets (3 mg Ivermectin), in healthy subjects under fasting conditions.

Conditions

• Anthelmintic Agent

Interventions

Type	Name	Description
DRUG	Ivermectin tablets (3 mg Ivermectin)	Two Ivermectin tablets were administered orally.
DRUG	Stromectol ® tablets	Two Ivermectin tablets were administered orally.

Timeline

• Start date: 2020-11-19
• Primary completion: 2020-12-21
• Completion: 2020-12-21
• First posted: 2021-10-19
• Last updated: 2023-12-13

Locations

1 site across 1 country: Jordan